The other weekend, I was talking with a friend about Parkinson’s Disease. One of our synagogue members is succumbing; during the discussion, my friend mentioned that his mom also suffered from the ailment. And, when I told him so did my grandfather, he mentioned how he was surprised that L-Dopa was the experimental treatment his mom tried- and that the doctor who was involved was at St. Barnabas in New York. To which I replied, he meant Dr. Bill Cooper- which blew him away. Because that was the name he was trying to draw up in his memory. It was pretty clear that we must have crossed paths some 47 years ago.
I have written before about the hope that stem cells offer to sufferers from Parkinson’s disease. Here’s yet another installment.
We have been seeking the ‘Holy Grail’ to treat Parkinson’s Disease with stem cells for some time. Given the restrictions on embryonic stem cells, research has been focused on integumentary and pluripotent stem cells. A big step forward has been made by a group of researchers working together, all from different institution. Drs. Lorenz Studer, Sonja Kriks & Jae-Won Shim of the Sloan Kettering Cancer Center in NY, along with other researchers there, plus researchers at the Cornell Medical School, Northwestern Medical, and Rush Memorial (the last two in Chicago, IL) published the results of their study in Nature on 10 November 2011.